Immunovant, Inc. — Director's Dealing 2022

Sep 29, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunovant, Inc. (IMVT)
CIK: 0001764013
Period of Report: 2022-09-29

Reporting Person: Torti Frank (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-29	Common Stock	P	20000	$5.81	Acquired	393358	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.68 - $5.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.